Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuhan Zhang

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Medicinal Research Reviews|June 2, 2025
3D Bioprinting for Engineering Organoids and Organ-on-a-Chip: Developments and ApplicationsYuqing Ren, Congying Yuan, Qimeng Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2025
Cancer-associated fibroblast-derived SEMA3C facilitates colorectal cancer liver metastasis via NRP2-mediated MAPK activationYuyuan Zhang, Anning Zuo, Yuhao Ba, et al.
Molecular Cancer|August 3, 2025
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapyYingying Lv, Zongshang Li, Shutong Liu, et al.
Cancer Communications (London, England)|February 2, 2026
The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer ImmunotherapyYingying Lv, Tingfei Duan, Jinling Song, et al.
Medcomm|October 30, 2024
Targeting immunosenescence for improved tumor immunotherapyZaoqu Liu, Lulu Zuo, Zhaokai Zhou, et al.
Bioactive Materials|December 24, 2025
Bacteria-responsive DNAgel system for targeted delivery of photothermally enhanced MXene/MoS<sub>2</sub> in the treatment of pyogenic osteomyelitisYun Jiang, Lixuen Siow, Kuoran Xing, et al.
Cell Proliferation|December 28, 2024
Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non-Viral CAR-NK Cell EngineeringZhaokai Zhou, Yifeng Chen, Yuhao Ba, et al.
Molecular Cancer|December 28, 2024
THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancerXing Zhou, Jiashu Han, Anning Zuo, et al.
Theranostics|April 14, 2025
FOS-driven inflammatory CAFs promote colorectal cancer liver metastasis via the SFRP1-FGFR2-HIF1 axisLong Liu, Yuhao Ba, Shuaixi Yang, et al.
Molecular Cancer|June 26, 2025
Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancerXing Zhou, Jiashu Han, Anning Zuo, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Medicinal Research Reviews|June 2, 2025
3D Bioprinting for Engineering Organoids and Organ-on-a-Chip: Developments and ApplicationsYuqing Ren, Congying Yuan, Qimeng Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2025
Cancer-associated fibroblast-derived SEMA3C facilitates colorectal cancer liver metastasis via NRP2-mediated MAPK activationYuyuan Zhang, Anning Zuo, Yuhao Ba, et al.
Molecular Cancer|August 3, 2025
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapyYingying Lv, Zongshang Li, Shutong Liu, et al.
Cancer Communications (London, England)|February 2, 2026
The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer ImmunotherapyYingying Lv, Tingfei Duan, Jinling Song, et al.
Medcomm|October 30, 2024
Targeting immunosenescence for improved tumor immunotherapyZaoqu Liu, Lulu Zuo, Zhaokai Zhou, et al.
Bioactive Materials|December 24, 2025
Bacteria-responsive DNAgel system for targeted delivery of photothermally enhanced MXene/MoS<sub>2</sub> in the treatment of pyogenic osteomyelitisYun Jiang, Lixuen Siow, Kuoran Xing, et al.
Cell Proliferation|December 28, 2024
Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non-Viral CAR-NK Cell EngineeringZhaokai Zhou, Yifeng Chen, Yuhao Ba, et al.
Molecular Cancer|December 28, 2024
THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancerXing Zhou, Jiashu Han, Anning Zuo, et al.
Theranostics|April 14, 2025
FOS-driven inflammatory CAFs promote colorectal cancer liver metastasis via the SFRP1-FGFR2-HIF1 axisLong Liu, Yuhao Ba, Shuaixi Yang, et al.
Molecular Cancer|June 26, 2025
Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancerXing Zhou, Jiashu Han, Anning Zuo, et al.
Pageof 8